RUNX2

RUNX2, or Runt-associated transcription factor 2, is a vital transcription factor primarily active in osteoblasts, where it influences bone development and maintenance by managing the expression of genes like osteocalcin and bone sialoprotein. Beyond its skeletal role, RUNX2 has gained interest in the field of oncology, as it may play a part in the emergence and progression of certain tumors, including osteosarcoma. Within the tumor microenvironment, RUNX2 is believed to affect the proliferation and invasion of tumor cells and to modulate the differentiation and function of immune cells, such as memory CD8+ T cells. Therefore, RUNX2's actions in bone development, tumorigenesis, and immune regulation make it a significant target for the study of immunotherapies in bone diseases and cancers.